The research related to the identification of new PAH biomarkers generally involves a GSEA analysis of key biomarkers, a TF/miRNA regulatory network and its enrichment analysis, and the expression verification of key genes (PMID: 32886110, PMID: 32849793, PMID: 35710932). Here, TF is linked to pulmonary arterial hypertension.